Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Fauci says leak concerns fueled his White House revelation of Gilead drug results

Published 04/30/2020, 02:39 AM
Updated 04/30/2020, 05:00 AM
© Reuters. Dr. Anthony Fauci attends Trump-Bel Edwards coronavirus response meeting at the White House in Washington

© Reuters. Dr. Anthony Fauci attends Trump-Bel Edwards coronavirus response meeting at the White House in Washington

By Julie Steenhuysen

CHICAGO (Reuters) - Concerns over leaks compelled the top U.S. infectious disease official to reveal data on Gilead Sciences (NASDAQ:GILD) Inc’s experimental drug remdesivir, the first in a scientifically rigorous clinical trial to show benefit in treating COVID-19.

The dramatic announcement by Dr Anthony Fauci in the Oval Office on Wednesday prompted concerns among scientists that the Trump administration was raising hopes about a coronavirus treatment before sharing the full data with researchers.

As a cautionary example of inflating the potential value of a therapy, some pointed to President Donald Trump’s repeated endorsements of malaria drug hydroxychloroquine as a treatment, with no evidence that it works.

Newer data suggests the malaria treatments may carry significant risks for some sufferers of the respiratory disease caused by the virus.

Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), which is running the trial, said he took the first opportunity to get the word out that patients taking a dummy treatment or placebo should be switched to remdesivir in hopes of benefiting from it.

He expressed concern that leaks of partial information would lead to confusion. Since the White House was not planning a daily virus briefing, Fauci said he was invited to release the news at a news conference with Louisiana Gov. John Bel Edwards(D). "It was purely driven by ethical concerns," Fauci told Reuters in a telephone interview.

"I would love to wait to present it at a scientific meeting, but it's just not in the cards when you have a situation where the ethical concern about getting the drug to people on placebo dominates the conversation."

An independent data safety and monitoring board, which had looked at the preliminary results of the NIAID trial, determined it had met its primary goal of reducing hospital stays.

On Tuesday evening, that information was conveyed in a conference call to scientists studying the drug globally.

"There are literally dozens and dozens of investigators around the world," Fauci said. "People were starting to leak it." But he did not give details of where the unreported data was being shared.

Several scientists interviewed by Reuters felt the White House setting seemed inappropriate for the release of highly anticipated government-funded trial data on the Gilead therapy.

They had expected it to be presented simultaneously in a detailed news release, a briefing at a medical meeting or in a scientific journal, allowing researchers to review the data.

Information from various trials of remdesivir has been leaked to media in recent weeks. In a statement on Wednesday, Gilead said the NIAID's much anticipated trial had met its primary goal, but gave no details.

Data in a separate NIAID statement after Fauci spoke detailed preliminary results showing that patients who got the drug had a 31 percent faster time to recovery than those who got a placebo, cutting hospital stays by four days.

The trial also came close to showing the drug helped people survive the disease, but the data fell just short of statistical significance.

"I want to see the full data. I want to understand the statistics. I want to understand the benefit and risk. I want to understand the structure of the study, and all of it," said Dr. Steven Nissen, the chief academic officer at the Cleveland Clinic.

"Am I encouraged from what I've heard? Yes, I'm encouraged. But I want to get a full understanding of what happened here, and not get it via a photo opportunity from the Oval Office."

Data Gilead released on its own trial of remdesivir drew less attention, as it did not compare outcomes between those receiving therapy and those who did not.

Results from a third study in China suggesting remdesivir failed to help COVID-19 patients were released in the British medical journal the Lancet after review by a peer group of scientists.

"That's the only thing I'll hang my hat on, and that was negative," said Dr. Eric Topol, director and founder of the Scripps Research Translational Institute in La Jolla, California.

He was unimpressed by remdesivir’s modest benefit.

"It was expected to be a whopping effect," Topol added. "It clearly does not have that."

At the Oval Office news conference, Fauci compared the study findings to AZT, the first drug to show any benefit against HIV, decades ago.

"We know that was an imperfect drug. It was the first step," Fauci said in the interview.

"Similar to AZT, it's (remdesivir) the first baby step towards what hopefully will be a number of better drugs that will come in and be able to treat people with COVID-19."

© Reuters. Dr. Anthony Fauci attends Trump-Bel Edwards coronavirus response meeting at the White House in Washington

(This story has been refiled to correct spelling of "clinical" in paragraph one)

Latest comments

Virus a CDC scam anyways. And the Trump Administration must know about it.
Everyone can tell there are atleast exactly two Trump supporters reading these comments, lmao
time line September... production starts in a week's time
fauci has put his reputation on line....this drug is not what it seems.....the company is evasive when it comes to full disclosure.....the only real thing...is the vaccine from Oxford...they will come out first....with a viable working solution....the back end production is being set up...in Pune India ,with the largest vaccine manufacturer in the world....they will manufacture and hold and once the efficacy test is proven they will distribute to those who want it....
Did the 'sharpest tack' in the Trump administration's 'toolbox' get played?
Yes and the only science we need to hear is from the vaccine left
yes back to Lysol injection, just keep increase the dosage, eventually it will ********off all the virus once the host is dead
#Firefauci
Market is pricing that all this mess will be over in 3 months. I think it will take at least a year or 2 to go back to normal. At least 6 months to go to a restaurant or holiday, then another 6 months to unemployment come down to the same level. Even after that many people will start to save money maybe first time in their lives. Psychological effect will take at least a year to heal I think. Fed can print money but cannot push people to spend same as before.
there a bunch of enablers to the Trump white House. science is very important. they are being shook up by Trump. it's all about his upcoming campaign election.
Its just an excuse the pump the market.
appreciate the timing, perfectly on time to break the resistance on the S&P. It remind me if the oil declarations some weeks ago, looks where oil is now.. I hope infected people will be more lucky than oil.
i had my wife make me a sandwich and her coronavirus went away. 100% cure rate based on my experiment. please pummp market and have women make sandwiches immediately to cure this virus.
so it's just hearsay, and not the real results? Did wall Street call up Dr.Fauci?
if it works for you - you'll only be in the hospital for 11 days not 15, fatalities were reduced from 11.8% to a little over 8% - no age statistics etc - patients seemed to get the same benefit from a 5 day regime as a 10 day regime but again not a lot of lesser statistics - not sure this is a overwhelming success but it will reduce some of the pressure on hospitals - unless of course they scr ew up the openings!
Med, sure thr r side effects, this virus off course hv side effects too. Then? The world shld b joyful we got some % of treatment which heal people. People will b huge infected soon.
Fauci: Mr.President! Trump: What?? you have it? you have vaccine?!  Fauci: No,no, i mean we just... Trump: shut up i'm tweeting
If Trump heard somebody said "We may have a vaccine in 2 years or more", you know he will immediately tweets "We have a vaccine!, and it's all because of me".  And then of course a week later he will deny he ever said such thing, and it's all fake news media's fault.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.